Altre lingue Cell Source, Inc.

Azioni

CLCS

US15114L1044

Mercato chiuso - OTC Markets Altri mercati azionari 20:57:38 19/04/2024			Variaz. 5gg	Var. 1 gen.
0,0002 ^USD	-99,95%		0,00%	-99,96%

2023	Cell Source, Inc. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI
2023	Cell Source, Inc. riporta i risultati degli utili per il secondo trimestre e i sei mesi conclusi il 30 giugno 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Cell Source, Inc. announced that it has received $4.76017 million in funding	22/03
Cell Source, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Cell Source, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	19/09/23
Cell Source, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23/08/23
Cell Source, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	08/08/23
Note 2 - Going Concern and Management Plans	08/12/22
Cell Source, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	08/12/22
Note 2 - Going Concern and Management Plans	02/12/22
Cell Source, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	02/12/22
Note 2 - Going Concern and Management Plans	02/11/22
Cell Source, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	02/11/22
CELL SOURCE, INC. : Change in Directors or Principal Officers (form 8-K)	21/07/22
Cell Source, Inc. Announces Board Resignations	21/07/22
CELL SOURCE, INC. : Change in Directors or Principal Officers (form 8-K)	06/05/22
Cell Source, Inc. Announces Resigation of Itamar Shimrat as A Director	06/05/22
CELL SOURCE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	15/04/22
Cell Source, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	15/04/22
Cell Source, Inc. Auditor Raises 'Going Concern' Doubt	15/04/22
Cell Source, Inc. Appoints George Verstraete as Member	11/03/22
CELL SOURCE, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers (form 8-K)	11/03/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Cell Source, Inc.

Azioni

CLCS

US15114L1044

Altre lingue

Filtri